Status:

COMPLETED

A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis

Lead Sponsor:

Kamuzu University of Health Sciences

Collaborating Sponsors:

British Society for Antimicrobial Chemotherapy

Conditions:

Candidiasis, Oral

Eligibility:

All Genders

Up to 14 years

Phase:

PHASE3

Brief Summary

In resource constrained societies and where HIV is a problem, oral thrush causes significant morbidity. In adults, ketoconazole is used and sometimes oral nystatin. Both drugs are relatively expensive...

Detailed Description

A double blind randomised trial of 2 strengths of GV solution and nystatin oral drops in the treatment of oropharyngeal candidiasis in children. Children with oral thrush were enrolled from the paedi...

Eligibility Criteria

Inclusion

  • All children up to 14 years of age with proven oral candidiasis

Exclusion

  • Children already on an antifungal agent or who had received an antifungal agent in the last week.

Key Trial Info

Start Date :

November 1 2002

Trial Type :

INTERVENTIONAL

End Date :

April 1 2005

Estimated Enrollment :

558 Patients enrolled

Trial Details

Trial ID

NCT00128323

Start Date

November 1 2002

End Date

April 1 2005

Last Update

February 11 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Queen Elizabeth Central Hospital, Paediatric Dept, Box 360

Blantyre, Malawi, 3